3 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5138 out of 5185 analysts
Average Return
-2.65%
Win Rate
39%215 out of 555
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +766.42% | $1.34 | $11.61 | 2025-04-14 - 2026-01-30 | Buy |
Cogent Biosciences IncCOGT | +576.27% | $5.31 | $35.91 | 2025-05-20 - 2026-01-30 | Buy |
Cogent Biosciences IncCOGT | +378.70% | $7.37 | $35.28 | 2025-01-14 - 2026-01-13 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-07 - 2020-09-14 | Buy |
Adc Therapeutics SaADCT | +287.50% | $0.80 | $3.10 | 2023-09-19 - 2024-09-18 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Perspective Therapeutics IncCATX | 6 | Buy | $12.00 | +216.62% | Maintains | 2 days ago |
Nurix Therapeutics IncNRIX | 21 | Buy | $32.00 | +93.70% | Maintains | 3 days ago |
Cardiff Oncology IncCRDF | 4 | Buy | $10.00 | +471.43% | Reiterates | 4 days ago |
Molecular Partners AgMOLN | 2 | Buy | $13.00 | +205.88% | Initiates Coverage On | 5 days ago |
Exelixis IncEXEL | 13 | Buy | $52.00 | +25.73% | Maintains | 5 days ago |
Adicet Bio IncACET | 3 | Buy | $50.00 | +525.78% | Maintains | 11 days ago |
Telix Pharmaceuticals LtdTLX | 4 | Buy | $20.00 | +174.73% | Reiterates | 11 days ago |
Nuvation Bio IncNUVB | 18 | Buy | $17.00 | +224.43% | Maintains | 20 days ago |
Tuhura Biosciences IncHURA | 4 | Buy | $10.00 | +1,769.16% | Reiterates | 23 days ago |
Cullinan Therapeutics IncCGEM | 4 | Buy | $27.00 | +125.75% | Maintains | 24 days ago |
Cogent Biosciences IncCOGT | 15 | Buy | $52.00 | +44.81% | Maintains | a month ago |
IMMIX Biopharma IncIMMX | 10 | Buy | $12.00 | +105.83% | Maintains | 2 months ago |
Zymeworks IncZYME | 23 | Buy | $32.00 | +42.03% | Maintains | 2 months ago |
Oric Pharmaceuticals IncORIC | 26 | Buy | $23.00 | +124.17% | Maintains | 3 months ago |
Biontech SeBNTX | 44 | Buy | $140.00 | +23.08% | Maintains | 3 months ago |
Revolution Medicines IncRVMD | 19 | Buy | $73.00 | -24.70% | Maintains | 3 months ago |
Caribou Biosciences IncCRBU | 15 | Buy | $9.00 | +538.30% | Maintains | 3 months ago |
Macrogenics IncMGNX | 19 | Hold | $2.00 | +9.29% | Reiterates | 3 months ago |
Fate Therapeutics IncFATE | 7 | Buy | $5.00 | +320.17% | Upgrades | 3 months ago |
Repare Therapeutics IncRPTX | 19 | Buy | $3.00 | +13.21% | Maintains | 3 months ago |
Replimune Group IncREPL | 17 | Buy | $12.00 | +70.70% | Upgrades | 3 months ago |
Bolt Biotherapeutics IncBOLT | 1 | Buy | $7.00 | +18.64% | Assumes | 3 months ago |
Adc Therapeutics SaADCT | 19 | Buy | $7.00 | +93.91% | Maintains | 4 months ago |
Karyopharm Therapeutics IncKPTI | 2 | Buy | $15.00 | +130.06% | Upgrades | 4 months ago |
Prelude Therapeutics IncPRLD | 17 | Buy | $5.00 | +170.27% | Reiterates | 4 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $27.00 | +130.38% | Initiates Coverage On | 5 months ago |
Onkure Therapeutics IncOKUR | 4 | Buy | $34.00 | +1,187.88% | Reiterates | 5 months ago |
Relay Therapeutics IncRLAY | 21 | Buy | $14.00 | +82.77% | Maintains | 5 months ago |
Bicara Therapeutics IncBCAX | 5 | Buy | $40.00 | +138.10% | Maintains | 5 months ago |
Arrivent Biopharma IncAVBP | 11 | Buy | $42.00 | +86.75% | Maintains | 6 months ago |
Black Diamond Therapeutics IncBDTX | 14 | Buy | $10.00 | +301.61% | Maintains | 6 months ago |
Y Mabs Therapeutics IncYMAB | 15 | Hold | $8.60 | -0.12% | Downgrades | 6 months ago |
Elicio Therapeutics IncELTX | 8 | Buy | $13.00 | +71.05% | Maintains | 6 months ago |
Enliven Therapeutics IncELVN | 5 | Buy | $48.00 | +81.47% | Maintains | 7 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | 9 months ago |
Tango Therapeutics IncTNGX | 12 | Buy | $13.00 | +11.97% | Reiterates | 10 months ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | +362.96% | Reiterates | 10 months ago |
Allogene Therapeutics IncALLO | 14 | Buy | $8.00 | +334.78% | Maintains | 10 months ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | N/A | Reiterates | a year ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | a year ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Alphaton Capital CorpATON | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 3 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 3 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 4 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 4 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.